CVS Health Corporation

NYSE:CVS Rapporto sulle azioni

Cap. di mercato: US$70.2b

CVS Health Gestione

Gestione criteri di controllo 2/4

CVS Health Il CEO è J. Joyner, nominato in Oct2024, ha un mandato di meno di un anno. possiede direttamente 0.003% delle azioni della società, per un valore di $ 2.27M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 6.8 anni.

Informazioni chiave

J. Joyner

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEO0.003%
Durata media del management2.3yrs
Durata media del Consiglio di amministrazione6.8yrs

Aggiornamenti recenti sulla gestione

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

Recent updates

CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet

Nov 03
CVS Health (NYSE:CVS) Has A Somewhat Strained Balance Sheet

CVS Health Stock Dip: Undervalued And Ready For A Turnaround

Oct 24

CVS Health: Glenview's Activism Ramps Up Pressure On Management

Sep 30

CVS Health: At Least There's A Valuable Lesson (Rating Downgrade)

Sep 10

A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

Aug 08
A Piece Of The Puzzle Missing From CVS Health Corporation's (NYSE:CVS) Share Price

CVS Health Q2 Earnings: CEO's Swinging Axe May Have Ended The Bear Run

Aug 07

Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

Jul 21
Here's Why CVS Health (NYSE:CVS) Has A Meaningful Debt Burden

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

AMMINISTRATORE DELEGATO

J. Joyner (59 yo)

less than a year

Mandato

Mr. J. David Joyner is President, CEO & Director of CVS Health Corporation from October 17, 2024 and served as Executive Vice President from January 30, 2023 to October 17, 2024 and was President of CVS Ca...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Thomas Cowhey
Executive VP & CFO1.1yrsUS$4.58m0.0028%
$ 2.0m
Tilak Mandadi
Executive VP of Ventures and Chief Digital2.3yrsUS$8.88m0.0032%
$ 2.3m
Samrat Khichi
Executive VP1.8yrsUS$11.89m0.00078%
$ 547.6k
Prem Shah
Executive VP3yrsUS$8.58m0.0037%
$ 2.6m
J. Joyner
Presidentless than a yearNessun dato0.0032%
$ 2.3m
Vijay Patel
Senior Director of Business Development & CVS Health and Partner & Co-Founderno dataNessun datoNessun dato
James Clark
Senior VP6yrsNessun dato0.00067%
$ 470.4k
David Falkowski
Executive VP & Chief Compliance Officerno dataNessun datoNessun dato
Heidi Capozzi
Executive VP & Chief People Officerless than a yearNessun datoNessun dato
Michelle Peluso
Executive VP and Chief Customer & Experience Officer3.8yrsNessun dato0.0099%
$ 6.9m
Joneigh Khaldun
VP & Chief Health Equity Officer3.1yrsNessun datoNessun dato
Kyu Rhee
Senior Vice Presidentno dataNessun datoNessun dato

2.3yrs

Durata media

55.5yo

Età media

Gestione esperta: Il team dirigenziale di CVS è considerato esperto (durata media dell'incarico 2.3 anni).


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
J. Joyner
Presidentless than a yearNessun dato0.0032%
$ 2.3m
J. Kirby
Independent Director1.1yrsUS$195.42k0.00045%
$ 315.9k
Roger Farah
Independent Chairman6yrsUS$576.50k0.00033%
$ 231.7k
Mary Schapiro
Independent Director7.5yrsUS$301.50k0.00094%
$ 660.0k
Nancy-Ann DeParle
Independent Director11.2yrsUS$321.50k0.0025%
$ 1.8m
Anne Finucane
Independent Director13.8yrsUS$321.50k0.0026%
$ 1.8m
C. Brown
Independent Director17.7yrsUS$321.50k0.0097%
$ 6.8m
Jean-Pierre Millon
Independent Director17.7yrsUS$321.50k0.0088%
$ 6.1m
Alecia DeCoudreaux
Independent Director9.7yrsUS$301.50k0.00024%
$ 168.5k
Fernando Aguirre
Independent Director6yrsUS$318.17k0.0028%
$ 2.0m
Jeffrey Balser
Independent Director2.2yrsUS$301.50k0.00058%
$ 407.2k
Michael Mahoney
Independent Directorless than a yearUS$167.50k0.0011%
$ 758.2k

6.8yrs

Durata media

67.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di CVS sono considerati esperti (durata media dell'incarico 6.8 anni).